Curiox Biosystems Co (XKRX:445680) ROCE % : 17.05% (As of Dec. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Curiox Biosystems Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Curiox Biosystems Co's annualized ROCE % for the quarter that ended in Dec. 2024 was 17.05%.

Curiox Biosystems Co ROCE % Historical Data

The historical data trend for Curiox Biosystems Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curiox Biosystems Co ROCE % Chart

Curiox Biosystems Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

ROCE %

Get a 7-Day Free Trial

-21.83

-97.29

-32.01

-20.19

-13.80

Curiox Biosystems Co Quarterly Data
	Dec19	Dec20	Dec21	Mar22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
ROCE %	Get a 7-Day Free Trial									-18.56	-20.66	-21.82	-30.61	17.05

Curiox Biosystems Co ROCE % Calculation

Curiox Biosystems Co's annualized ROCE % for the fiscal year that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	-7293.794	/	( ( (57797.994 - 2716.568)	+	(70560.574 - 19917.655) )	/ 2 )
	=	-7293.794	/	( (55081.426	+	50642.919)	/ 2 )
	=	-7293.794	/	52862.1725
	=	-13.80 %

Curiox Biosystems Co's ROCE % of for the quarter that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	8380.532	/	( ( (72236.998 - 24557.158)	+	(70560.574 - 19917.655) )	/ 2 )
	=	8380.532	/	( ( 47679.84	+	50642.919 )	/ 2 )
	=	8380.532	/	49161.3795
	=	17.05 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2024) EBIT data.

Curiox Biosystems Co (XKRX:445680) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Curiox Biosystems Co ROCE % Related Terms

Thank you for viewing the detailed overview of Curiox Biosystems Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Curiox Biosystems Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Curiox Biosystems Co Ltd (XKRX:445680) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Samsung Harrington IT Tower, 204-213, 202, 2nd Floor, 9 Gil 41 Digital-Ro, Geumchun-Gu, Seoul, KOR, 08511

Website

https://www.curiox.co.kr

Curiox Biosystems Co Ltd is Korean Based company which brings together decades of scientific and engineering expertise in surface chemistry and life science instrumentation with the goal of overcoming critical challenges that slow the pace of life science research. The company has introduced Laminar Wash technology, which automates cell processing and enables highly reproducible and high-throughput cell analysis. The company offers various products such as LAMINAR WASH AUTO 1000 SYSTEM, Curiox Laminar Wash HT2000 System and Laminar Wash MINI System.

Curiox Biosystems Co Headlines

No Headlines